|
Name |
n-Octanoic acid,methyl(tetramethylene)silyl ester
|
Molecular Formula | C13H26O2Si | |
IUPAC Name* |
(1-methylsilolan-1-yl) octanoate
|
|
SMILES |
CCCCCCCC(=O)O[Si]1(CCCC1)C
|
|
InChI |
InChI=1S/C13H26O2Si/c1-3-4-5-6-7-10-13(14)15-16(2)11-8-9-12-16/h3-12H2,1-2H3
|
|
InChIKey |
KSSOOHVPSFPMCF-UHFFFAOYSA-N
|
|
Synonyms |
n-Octanoic acid,methyl(tetramethylene)silyl ester; 1-Methyl-1-silolanyl octanoate #
|
|
CAS | NA | |
PubChem CID | 611574 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 242.43 | ALogp: | 4.3 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 8 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 26.3 | Aromatic Rings: | 1 |
Heavy Atoms: | 16 | QED Weighted: | 0.472 |
Caco-2 Permeability: | -4.648 | MDCK Permeability: | 0.00003190 |
Pgp-inhibitor: | 0.963 | Pgp-substrate: | 0.056 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.782 |
30% Bioavailability (F30%): | 0.238 |
Blood-Brain-Barrier Penetration (BBB): | 0.029 | Plasma Protein Binding (PPB): | 99.29% |
Volume Distribution (VD): | 1.253 | Fu: | 0.94% |
CYP1A2-inhibitor: | 0.77 | CYP1A2-substrate: | 0.368 |
CYP2C19-inhibitor: | 0.101 | CYP2C19-substrate: | 0.285 |
CYP2C9-inhibitor: | 0.383 | CYP2C9-substrate: | 0.933 |
CYP2D6-inhibitor: | 0.008 | CYP2D6-substrate: | 0.048 |
CYP3A4-inhibitor: | 0.051 | CYP3A4-substrate: | 0.026 |
Clearance (CL): | 3.484 | Half-life (T1/2): | 0.534 |
hERG Blockers: | 0.007 | Human Hepatotoxicity (H-HT): | 0.052 |
Drug-inuced Liver Injury (DILI): | 0.086 | AMES Toxicity: | 0.006 |
Rat Oral Acute Toxicity: | 0.007 | Maximum Recommended Daily Dose: | 0.778 |
Skin Sensitization: | 0.947 | Carcinogencity: | 0.203 |
Eye Corrosion: | 0.976 | Eye Irritation: | 0.958 |
Respiratory Toxicity: | 0.813 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000253 | 0.531 | D0AY9Q | 0.318 | ||||
ENC001390 | 0.492 | D0XN8C | 0.300 | ||||
ENC000249 | 0.473 | D03ZJE | 0.300 | ||||
ENC000454 | 0.469 | D09ANG | 0.280 | ||||
ENC000248 | 0.448 | D02AXG | 0.275 | ||||
ENC000451 | 0.442 | D0G2KD | 0.274 | ||||
ENC000687 | 0.440 | D0E4WR | 0.270 | ||||
ENC000030 | 0.440 | D0H2YX | 0.267 | ||||
ENC000260 | 0.426 | D0Z5BC | 0.266 | ||||
ENC000265 | 0.418 | D07ILQ | 0.265 |